RxDoctor Payments Data

Sumeet Arora, DO

Interventional Pain Medicine · Clifton, NJNPI 1831443357

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $785 and has fallen 71.8% since, to $222 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in NJ, where the typical reported total is $3,760.

$2,324in general payments, 2019–2025

Across 97 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$445
  • Si-bone, Inc.$386
  • Boston Scientific$335
  • Biotronik NRO, Inc.$313
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$174
  • Collegium Pharmaceutical, Inc.$159
  • plus $512 from 16 others

What the payments were for

  • Food & beverage$2,324100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,324 in reported general payments places this provider in the 35th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$93,816
Medicare patients
136
Services billed
827

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen133$2,243
Lidocaine36$2,084
Pregabalin18$1,909
Oxycodone Hcl92$1,687
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen68$983
Methadone Hcl23$981
Morphine Sulfate ErMorphine Sulfate20$939
Gabapentin74$774
Morphine Sulfate17$763
Diclofenac Sodium28$651
Duloxetine Hcl17$644
Tizanidine Hcl29$585
Cyclobenzaprine Hcl77$403
Meloxicam45$249
Tramadol Hcl46$190

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Clifton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →